Updated just now · Live
Stock analysis, price data, and AI-powered insights for 10X Genomics Inc (TXG).
10X Genomics Inc operates in the Life Sciences Tools & Services sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for TXG.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). TXG Stock Intelligence Report. [stoxpulse.com/stocks/txg]
Disclaimer: The information on this page about 10X Genomics Inc (TXG) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for 10X Genomics Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Canaccord Genuity Maintains Buy on 10x Genomics, R...
1d ago
B of A Securities Maintains Neutral on 10x Genomic...
1d ago
StoxPulse AI results for TXG: Pulse Score 54/100. Primary sentiment trends from 5 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$3.14B
P/E Ratio
—
EPS
$-0.22
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Canaccord Genuity Maintains Buy on 10x Genomics, Raises Price Target to $32
B of A Securities Maintains Neutral on 10x Genomics, Raises Price Target to $30
Reported Earlier, 10x Genomics Announced Atera, A New In Situ Spatial Biology Platform Engineered To Deliver Whole-transcriptome Spatial Analysis With Single-cell Sensitivity At Unprecedented Scale
10x Genomics : Introduces Atera
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood